DE69009538T2 - In der Therapeutik anwendbare Zusammensetzung mit aggregationshemmender Wirkung auf Blutplättchen. - Google Patents

In der Therapeutik anwendbare Zusammensetzung mit aggregationshemmender Wirkung auf Blutplättchen.

Info

Publication number
DE69009538T2
DE69009538T2 DE69009538T DE69009538T DE69009538T2 DE 69009538 T2 DE69009538 T2 DE 69009538T2 DE 69009538 T DE69009538 T DE 69009538T DE 69009538 T DE69009538 T DE 69009538T DE 69009538 T2 DE69009538 T2 DE 69009538T2
Authority
DE
Germany
Prior art keywords
platelets
therapeutic composition
aggregation effects
composition
aggregation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69009538T
Other languages
English (en)
Other versions
DE69009538D1 (de
Inventor
Jesus Covarrubias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott France SA
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Procter and Gamble Pharmaceuticals France SA
Procter and Gamble Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Pharmaceuticals France SA, Procter and Gamble Pharmaceuticals Inc filed Critical Procter and Gamble Pharmaceuticals France SA
Application granted granted Critical
Publication of DE69009538D1 publication Critical patent/DE69009538D1/de
Publication of DE69009538T2 publication Critical patent/DE69009538T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
DE69009538T 1989-03-10 1990-03-06 In der Therapeutik anwendbare Zusammensetzung mit aggregationshemmender Wirkung auf Blutplättchen. Expired - Fee Related DE69009538T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903138A FR2644061A1 (fr) 1989-03-10 1989-03-10 Composition a activite antiagregante plaquettaire utilisable en therapeutique

Publications (2)

Publication Number Publication Date
DE69009538D1 DE69009538D1 (de) 1994-07-14
DE69009538T2 true DE69009538T2 (de) 1995-01-12

Family

ID=9379557

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69009538T Expired - Fee Related DE69009538T2 (de) 1989-03-10 1990-03-06 In der Therapeutik anwendbare Zusammensetzung mit aggregationshemmender Wirkung auf Blutplättchen.

Country Status (10)

Country Link
EP (1) EP0387140B1 (de)
JP (1) JP2935138B2 (de)
KR (1) KR0169118B1 (de)
AT (1) ATE106733T1 (de)
CA (1) CA2027593C (de)
DE (1) DE69009538T2 (de)
ES (1) ES2058832T3 (de)
FR (1) FR2644061A1 (de)
MX (1) MX174250B (de)
WO (1) WO1990010447A1 (de)

Also Published As

Publication number Publication date
EP0387140A1 (de) 1990-09-12
ATE106733T1 (de) 1994-06-15
KR920700037A (ko) 1992-02-19
JP2935138B2 (ja) 1999-08-16
MX174250B (es) 1994-05-02
WO1990010447A1 (fr) 1990-09-20
JPH03504509A (ja) 1991-10-03
CA2027593A1 (fr) 1990-09-11
KR0169118B1 (ko) 1999-01-15
ES2058832T3 (es) 1994-11-01
FR2644061B1 (de) 1994-04-22
DE69009538D1 (de) 1994-07-14
CA2027593C (fr) 2001-01-02
EP0387140B1 (de) 1994-06-08
FR2644061A1 (fr) 1990-09-14

Similar Documents

Publication Publication Date Title
DE3855096D1 (de) Hemmung von arteriellem thrombotischen Verschluss oder von Thrombo-Embolismus
IT7921854A0 (it) Impiego di antiestrogeni e antiandrogeni ad azione antigonadotropa per la profilassi e la terapia della iperplasia prostatica.
DE68929279T2 (de) Lederbehandlung mit ausgewählten amphiphilen Copolymeren
DK617388A (da) 1,1-dimethyl-2-oxa-4-aminoindanderivater, deres fremstilling og anvendelse som fungicider
ES524992A0 (es) Procedimiento para higienizar o pasterizar fribrinogeno humano
ATE104151T1 (de) Trombosebehandlung mit fibrinolytika und prostacyclinen.
DE68905241T2 (de) Tracheobronchodilatator.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
NO871053D0 (no) Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DK627687D0 (da) Hirudinvariant
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
DE59002185D1 (de) Kombinationspraeparat mit antithrombotischer wirkung.
DE69009538T2 (de) In der Therapeutik anwendbare Zusammensetzung mit aggregationshemmender Wirkung auf Blutplättchen.
NO894008D0 (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DE68926334T2 (de) Textilbehandlungsmittel
SE8802040D0 (sv) New use
DK301589A (da) Laegemiddel med thrombolytisk virkning
ES2054599T1 (es) Utilizacion de valina-dl, sus esteres y/o sales para combatir la caspa.
IT209939Z2 (it) Apparecchio per abbronzatura artificiale del viso e delle mani a mezzo di lampade autonome.
SE8701177L (sv) Arbetsmoebel med staellbart stativ
DK674087D0 (da) Saarbehandlingsmiddel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee